Related Experiment Video
Updated: Jul 2, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
The Global Epidemic of Metabolic Fatty Liver Disease
Ethan C Z Lee1, Vickram V Anand1, Alex C Razavi2
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Purpose Of Review:
The objective of this manuscript is to examine the current literature on the epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD), its correlation with cardiovascular disease (CVD) outcomes, as well as to evaluate the update in nomenclature from non-alcoholic liver disease (NAFLD).
Recent Findings:
The update of diagnostic criteria from NAFLD to MASLD reduces the stigma associated with alcohol consumption and poor health choices. It also shines a light on the crucial role of cardiometabolic risk factors in disease pathophysiology. The incidence and prevalence of MASLD are projected to increase significantly in the future as the population burden of cardiometabolic risk factors rises. MASLD is also a potent risk factor for developing CVD that should be tackled by using a multi-disciplinary team with a holistic approach. As the new nomenclature for metabolic liver disease is adopted on a global scale, more research is needed to investigate the applicability of findings from previous trials focusing on NAFLD. It is anticipated that the epidemic of MASLD will continue to increase globally, hence the urgent need for therapeutic approaches to reverse this trend.
Insights
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, strongly linked to cardiovascular disease (CVD). The shift from NAFLD to MASLD highlights the importance of metabolic factors and necessitates further research into effective treatments.
Area of Science:
- Hepatology and Gastroenterology
- Cardiology
- Metabolic Diseases
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly NAFLD, is increasingly prevalent.
- Cardiometabolic risk factors are central to MASLD pathophysiology.
- MASLD is a significant risk factor for cardiovascular disease (CVD).
Purpose of the Study:
- To review the epidemiology of MASLD.
- To examine the association between MASLD and CVD outcomes.
- To evaluate the impact of the nomenclature change from NAFLD to MASLD.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of research on MASLD and CVD correlations.
- Evaluation of diagnostic criteria updates.
Main Results:
- The MASLD nomenclature reduces stigma and emphasizes metabolic factors.
- MASLD incidence and prevalence are rising due to increasing cardiometabolic risk.
- MASLD is a potent risk factor for CVD, requiring a multidisciplinary approach.
Conclusions:
- The global epidemic of MASLD is expected to grow.
- Further research is needed to validate findings from previous NAFLD studies under the new MASLD criteria.
- Urgent development of therapeutic strategies is required to combat the rising trend of MASLD.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Obesity
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Metabolic States of the Body: Fasting and Starvation

